glp-1 agonists names Market to Reach $170.75B by 2033 | Mayuri Lamba posted on the topic Best Med #2: GLP-1 Receptor
Description
On further time-based analysis, we demonstrated a modest reduction in weight with GLP-1 RA use within the first 3 years (2.7% of baseline body weight) before rebounding to above baseline at 5 years
Abushanab D, Marquina C, Morton JI, et al
This hormone plays a key role in regulating blood sugar, appetite, and digestion
Gandy, S
